SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-16-093494
Filing Date
2016-02-03
Accepted
2016-02-03 13:17:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT a16-3298_1sc13ga.htm SC 13G/A 72608
  Complete submission text file 0001104659-16-093494.txt   74007
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46083 | Film No.: 161384088
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3653 MAPLEWOOD AVENUE DALLAS TX 75205
Business Address
MEAD ROBERT E (Filed by) CIK: 0001040747 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000